50% off Premium Yearly

NASDAQ:CRNC
This summary was created by AI, based on 1 opinions in the last 12 months.
Cerence (CRNC-Q) has been receiving mixed reviews from experts, particularly highlighting a significant stance against investing in enterprise software. The sentiment suggests a cautious approach towards the stock, indicating that it might not be ripe for investment at this time. Despite the innovative offerings that Cerence presents, the overarching view reflects reluctance and hesitance to commit to enterprise solutions. This leads to a broader conversation around the current market dynamics and the evolving landscape of software investments. Experts appear to be exploring alternative avenues, reflecting the broader industry sentiment towards enterprise solutions.
CRNC had a very strong recent quarter, with EPS nearly double estimates. Sales were 4% better than expected. EBITDA was 48% better. It is up 200% in a year and trades at 44X earnings. Certainly stock and fundamental momentum is very solid here. Net debt is a bit high at 3X cash flow, and its small size adds risks. EPS is also expected to dip this year from very strong recent numbers. Insiders own 9% and have been buyers this year. The 2025 forecast did beat estimates. It has some good partnerships with companies such as ARM. The sector is also poised for growth, as noted with some regulatory help. It looks good for a small cap, though is pricey and due to its size risk we would size a position accordingly.
Unlock Premium - Try 5i Free
The world leader in car voice and A.I. that connects to third-party apps, like Starbucks, in 325 million cars worldwide, including 50% of every car sold in 2020. Shares have had a huge run, from $15 to $111 after Nuance spun it off two years ago. Yet, shares are down $20 from this year's highs.
Yet another software development company in a crowded field that Microsoft dominates.
Cerence is a American stock, trading under the symbol CRNC (previously CRNC-Q on Stockchase) on the NASDAQ (CRNC). It is usually referred to as NASDAQ:CRNC or CRNC
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on CRNC (previously CRNC-Q on Stockchase). 0 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Cerence.
Cerence was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Cerence.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Cerence.
Cerence is followed by 8 investors on Stockchase and is a trending stock that is worth watching.
On 2026-08-21, Cerence (CRNC) stock closed at a price of $8.05.
He isn't buying any enterprise software.